Literature DB >> 27594409

Analysis of Heteroplasmic Variants in the Cardiac Mitochondrial Genome of Individuals with Down Syndrome.

Erik Hefti1, Jonathan Bard2, Javier G Blanco1.   

Abstract

Individuals with Down syndrome (DS, trisomy 21) exhibit a pro-oxidative cellular environment as well as mitochondrial dysfunction. Increased oxidative stress may damage the mitochondrial DNA (mtDNA). The coexistence of mtDNA variants in a cell or tissue (i.e., heteroplasmy) may contribute to mitochondrial dysfunction. Given the evidence on mitochondrial dysfunction and the relatively high incidence of multiorganic disorders associated with DS, we hypothesized that cardiac tissue from subjects with DS may exhibit higher frequencies of mtDNA variants in comparison to cardiac tissue from donors without DS. This study documents the analysis of mtDNA variants in heart tissue samples from donors with (n = 12) and without DS (n = 33) using massively parallel sequencing. Contrary to the original hypothesis, the study's findings suggest that the cardiac mitochondrial genomes from individuals with and without DS exhibit many similarities in terms of (1) total number of mtDNA variants per sample, (2) the frequency of mtDNA variants, (3) the type of mtDNA variants, and (4) the patterns of distribution of mtDNA variants. In both groups of samples, the mtDNA control region showed significantly more heteroplasmic variants in comparison to the number of variants in protein- and RNA-coding genes (P < 1.00×10-4 , ANOVA).
© 2016 WILEY PERIODICALS, INC.

Entities:  

Keywords:  Down syndrome; cardiac; heteroplasmy; massively parallel sequencing; mitochondrial variants; trisomy 21

Mesh:

Substances:

Year:  2016        PMID: 27594409      PMCID: PMC5154832          DOI: 10.1002/humu.23071

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  35 in total

1.  Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome.

Authors:  Vittoria Infantino; Alessandra Castegna; Francesco Iacobazzi; Iolanda Spera; Iris Scala; Generoso Andria; Vito Iacobazzi
Journal:  Mol Genet Metab       Date:  2010-12-09       Impact factor: 4.797

2.  Alternative, simultaneous complex I mitochondrial DNA mutations in Leber's hereditary optic neuropathy.

Authors:  D R Johns; J Berman
Journal:  Biochem Biophys Res Commun       Date:  1991-02-14       Impact factor: 3.575

3.  The triple challenges associated with age-related comorbidities in Down syndrome.

Authors:  E J Glasson; D E Dye; A H Bittles
Journal:  J Intellect Disabil Res       Date:  2013-03-19

Review 4.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

Review 5.  Mitochondria and cardiovascular aging.

Authors:  Dao-Fu Dai; Peter S Rabinovitch; Zoltan Ungvari
Journal:  Circ Res       Date:  2012-04-13       Impact factor: 17.367

Review 6.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

7.  Evidence for cardiomyocyte renewal in humans.

Authors:  Olaf Bergmann; Ratan D Bhardwaj; Samuel Bernard; Sofia Zdunek; Fanie Barnabé-Heider; Stuart Walsh; Joel Zupicich; Kanar Alkass; Bruce A Buchholz; Henrik Druid; Stefan Jovinge; Jonas Frisén
Journal:  Science       Date:  2009-04-03       Impact factor: 47.728

8.  Development of a CART Model to Predict the Synthesis of Cardiotoxic Daunorubicinol in Heart Tissue Samples From Donors With and Without Down Syndrome.

Authors:  Carrie C Hoefer; Rachael Hageman Blair; Javier G Blanco
Journal:  J Pharm Sci       Date:  2016-04-23       Impact factor: 3.534

9.  Oxidative Stress and Mitochondrial Dysfunction in Down's Syndrome: Relevance to Aging and Dementia.

Authors:  Pinar E Coskun; Jorge Busciglio
Journal:  Curr Gerontol Geriatr Res       Date:  2012-04-29

10.  Heteroplasmic mitochondrial DNA mutations in normal and tumour cells.

Authors:  Yiping He; Jian Wu; Devin C Dressman; Christine Iacobuzio-Donahue; Sanford D Markowitz; Victor E Velculescu; Luis A Diaz; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos
Journal:  Nature       Date:  2010-03-03       Impact factor: 49.962

View more
  2 in total

1.  Mitochondrial DNA heteroplasmy in cardiac tissue from individuals with and without coronary artery disease.

Authors:  Erik Hefti; Javier Guillermo Blanco
Journal:  Mitochondrial DNA A DNA Mapp Seq Anal       Date:  2017-05-19       Impact factor: 1.514

2.  Neurochemical and Behavior Deficits in Rats with Iron and Rotenone Co-treatment: Role of Redox Imbalance and Neuroprotection by Biochanin A.

Authors:  Lijia Yu; Xijin Wang; Hanqing Chen; Zhiqiang Yan; Meihua Wang; Yunhong Li
Journal:  Front Neurosci       Date:  2017-11-23       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.